Form D · Biotechnology
INSITE VISION INC
Alameda, CA · CIK 0000802724
Offering snapshot reported Oct 24, 2014 · SEC filing
- Reported sold
- $2.38M Offering amount: $15M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 9, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2014 | Initial | $2,381,666 | No comparison | 17 | SEC filing |
| Jul 22, 2011 | Initial | $22,187,064 | No comparison | 27 | SEC filing |
| Aug 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 12, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 7, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $143K
- Finders' fees
- $0
- Form D file number
- 021-227061
The offering includes up to $15,000,000 principal amount of senior secured promissory notes and warrants to purchase an indefinite number of common shares. Warrants to acquire a total of 2,053,169 common shares at $0.33 per share were issued on 10/9/2014.
Riverbank Capital Securities, Inc. is to receive a cash commission equal to 6% of the gross proceeds from the sale of any additional senior secured promissory notes in this offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Riverbank Capital Securities, Inc. | 135310 |
Source: Form D, filed Oct 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rick Anderson | Director |
| Lyle M. Bowman | Executive |
| Louis Drapeau | Executive |
| Kamran Hosseini | Executive |
| Brian Levy | Director |
| Timothy P. Lynch | Director |
| Timothy Mc Inerney | Director |
| Evan S. Melrose | Director |
| Robert O'holla | Director |
| Surendra Patel | Executive |
| Timothy Ruane | Director, Executive |
| Craig Tooman | Director |
| Anthony J. Yost | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
965 Atlantic Ave.
Alameda, CA, 94501
Alameda, CA, 94501